Martin Smoragiewicz

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

Jenny J. Ko, Wanling Xie, Nils Kroeger et al. · The Lancet Oncology · 2015 · 364 citations · Full text

First-line Targeted Therapy, Urology, Population-based Study +6

CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response

Daniele Biasci, Martin Smoragiewicz, Claire M. Connell et al. · Proceedings of the National Academy of Sciences · 2020 · 241 citations · Full text

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy

Arnoud J. Templeton, Jennifer J. Knox, Xun Lin et al. · European Urology · 2016 · 147 citations · Full text

Urology, Cancer Immunosurveillance, Genitourinary Cancer +8

Characterizing the Impact of Lymph Node Metastases on the Survival Outcome for Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapies

Nils Kroeger, Allan J. Pantuck, J. Connor Wells et al. · European Urology · 2014 · 43 citations

Urology, Genitourinary Cancer, Medicine +8

Risk factors and model for predicting toxicity‐related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Marina D. Kaymakcalan, Wanling Xie, Laurence Albigès et al. · Cancer · 2015 · 35 citations · Full text